THE WHOLE SOY STORY
THE DARK SIDE OF AMERICA'S FAVORITE HEALTH FOOD
By Kaayla T. Daniel
![]()
ENDNOTES
NOTE TO READERS: For a full discussion of all issues and complete citations see The Whole Soy Story by Kaayla T. Daniel (New Trends, 2004) or visit the website www.wholesoystory.com.
1. Golbitz P. Soyfoods Consumption in the United States and
Worldwide: A Statistical Analysis. Soyatech Inc, Bar Harbor, ME.
2. Organisation for Economic Co-operation and Development. Food Consumption
Statistics. (Paris, OECD Publications, 1991).
3. Information about soy and agriculture can be found in Nutritional Anthropology
(Liss, 1987) edited by Francis Johnston. For the history of miso, soy sauce,
tempeh, tofu and other products see William Shurtleff and Akiko Aoyagi's
The Book of Miso (Ten Speed Press, 1976) The Book of Tofu (Ballentine, 1979)
and The Book of Tempeh (Ten Speed Press, 1979). Information about the history
of soy, including modern manufacturing processes can be found in KeShun Liu's
Soybeans: Chemistry, Technology and Utilization (Aspen, 1999).
4. Shurtleff, William. Aoyagi, Akiko. The History of Soybean Crushing: Soy
Oil and Soybean Meal. From The History of Soybeans and Soyfoods: Past, Present
and Future. Unpublished manuscript. Soyfoods Center, Lafayette, CA.
5. Shurtleff, William. Chronology of Soymilk Worldwide: Part I: 220AD to
1949. Special Exhibit, Museum of Soy, 2001, www.soydailyclub.com.
6. Guy RA. The diets of nursing mothers and young children in Peiping. Chinese
Med J, 1936, 50, 434-442.
7. Guy RA, Yeh KS. Roasted soybean in infant feeding. Chinese Med J, 1938,
54, 2, 101-110.
8. Guy RA, Yeh KS. Soybean "milk" as a food for young infants. Chinese Med
J, 1938, 54, 1, 1-30.
9. Miller HW. Survey of soyfoods in East Asia, Soybean Digest, June 1948,
22-23. Summarized in Shurtleff, William and Aoyagi, Akiko. Bibliography and
Sourcebook on Seventh Day Adventists, 1866-1992 (Lafayette, CA. Soyfoods
Center), 74.
10. Tso, Ernest, The development of an infant fed eight months on a soybean
milk Diet, Chinese J Physiol, 1928, Vol. 2, no. 1, pp. 33-40.
11. Chou, C.Y., Studies on the use of soybean food in infant feeding in China
and the development of formula. Unpublished 1983 manuscript in the possession
of Bernard Zimmerli at the Federal Office of Health, Berne, Switzerland.
12. Guy.
13. Guy, Yeh. #7
14. Guy, Yeh. #8
15. Toxicologist Michael Fitzpatrick, Ph.D., as quoted by the Soy Information
Network Newsletter, March 5, 1996, pp. 6-7.
16. Liu, KeShun. Soybeans: Chemistry, Technology and Utilization (Aspen,
1999). 379-411.
17. Erickson, David R ed. Practical Handbook of Soybean Processing and Utilization
(AOCS Press, 1995).
18. Visser A, Thomas A. Review: Soya protein products - their processing,
functionality and application aspects. Food Rev Inter, 1987, 3, 1&2,
220, 1-32.
19. Berk, Zeki. Technology of production of edible flours and protein products
from soybeans. FAO Bulletin, Food and Agricultural Organization of the United
Nations, Rome, 1992, 24.
20. Liu. 425-436.
21. Liu, 386-388
22. Lusas EW, Rhee KC. Soybean protein processing and utilization. In Erickson,
138-146.
23. SCOGS-101. Evaluation of the health aspects of soy protein isolates as
food ingredients. 1979. Prepared for Bureau of Foods, US Food and Drug Administration
by the Life Sciences Research Office (FASEB).
24. Rackis JJ. Biologically active components. In Smith, Allan K and Circle,
Sidney J eds. Soybeans: Chemistry and Technology, Vol 1 (Westport CT, Avi
Publishing, 1972).
25. Liener IE, Kakade ML. Protease inhibitors. In Liener IE, ed. Toxic Constituents
in Plant Foodstuffs (NY Academic Press, 1980). 7-71.
26. Liener IE. Trypsin inhibitors: Concern for human nutrition or not? J
Nutr, 1986, 116, 5, 921.
27. Anderson RL, Wolfe WJ. Composition changes in trypsin inhibitors, phytic
acid, saponins and isoflavones related to soybean processing. J Nutr, 1995,
125, 581S-588S.
28. Rackis JJ, Gumbmann MR. Protease inhibitors physiological properties
and nutritional significance. In Ory, Robert L ed. Antinutrients and Natural
Toxicants in Foods (Food and Nutrition Press, 1981), 203-238.
29. Reddy NR, Sathe SK eds. Food Phytates (CRC Press, 2002).
30. Hurrell RF et al. Soy protein, phytate and iron absorption in humans.
Am J Clin Nutr, 1992, 56, 3, 573-578.
31. Lonnerdal B, Bell JG et al. Effects of phytate removal on zinc absorption
from soy formula. Am J Clin Nutr, 1988, 48, 5, 1301-1306.
32. Davidsson L, Galan P et al. Iron bioavailability studied in infants:
the influence of phytic acid and ascorbic acid in infant formulas based on
soy isolate. Pediatr Res, 1994, 36, 6, 816-822.
33. Cook JD, Morck TA. Lynch SR. The inhibitory effects of soy products on
non-heme absorption in man. Am J Clin Nutr, 1981, 34, 12, 2622-2629.
34. Shaw N-S, Chin C-J, Pan W-H. A vegetarian diet rich in soybean products
compromises iron status in young students. J Nutr, 1995, 125, 212-219.
35. Pusztai, Arpad. Plant Lectins (Cambridge University Press, 1991).
36. Seeman P, Cheng D, Hes GH. Structure of membrane holes in osmotic and
saponin hemolysis. J Cell Biol, 1973, 56, 2, 519-527.
37. Massey LK, Palmer RG, Horner HT. Oxalate content of soybean seeds (Glycine
max: Leguminosae), soyfoods and other edible legumes. J Agric Food Chem,
2001, 49, 9, 4262-4266.
38. Solomon, Clive. www.vulvarpainfoundation.org/low oxalatetreatment.htm.
39. Suarez FL, Springfield J et al. Gas production in humans ingesting a
soybean flour derived from beans naturally low in oligosaccharides Am J Clin
Nutr, 1999, 69, 1, 135-139.
40. Visser A, Thomas A. Review: Soya protein products, their processing,
functionality and application aspects. Food Rev Inter, 1987, 3, (1&2)
1-32.
41. Anderson, Wolfe.
42. Rackis. Gumbmann.
43. Peace RW, Sarwar G et al. Trypsin inhibitor levels in soy-based infant
formulas and commercial soy protein isolates and concentrates. Food Res Int
1992, 25, 137-141.
44. Billings PC, Longnecker MP et al. Protease inhibitor content of human
dietary samples. Nutr Cancer, 1990, 14, 2, 85-93.
45. Kennedy AR. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic
agent. Am J Clin Nutr, 1998, 68 (suppl), 1406S-1412S.
46. Sidhu GS, Oakenfull DG. A mechanism for the hypocholesterolemic activity
of saponins. Br J Nutr, 1986, 7, 55, 643.
47. Rao AV. Sung MK. Saponins as anticarcinogens. J Nutr, 1995, 125, 717S-724S.
48. Doyle R, Keller K. Lectins in diagnostic microbiology. Eur J Clin Microbiol,
1983, 3, 4-9.
49. Shamsuddin AM, Yang GY, Vucenik I. Novel anti-cancer function of IP6:
growth inhibition and differentiation of human mammary cancer cell lines
in vitro. Anticancer Res, 1996, 16 (6A) 3287-3292.
50. Baten A, Ullah A et al. Inositol-phosphate induced enhancement of natural
killer cell activity correlates with tumor suppression. Carcinogenesis, 1989,
10, 9 1595-1598.
51. Jenab M, Thompson LU. Role of phytic acid in cancer and other diseases.
In Reddy, Sathe. 225-248.
52. FAO Food Allergies Report of the Technical Consultation of the Food and
Agricultural Organization of the United Nations, Rome, November 13-14, 1995.
53. Bousquet J, Bjorksten B et al. Scientific criteria and selection of allergenic
foods for labeling. Allergy, 1998, 53 (Suppl 47) 3-21.
54. Keeler, Barbara. A nation of lab rats, Sierra Club Magazine, July/August
2001.
55. Foucard T, Malmheden-Yman I. A study on severe food reactions in Sweden
- is soy protein an underestimated cause of food anaphylaxis. Allergy, 1999,
53, 3, 261-265.
56. Letter from Ingrid Malmheden-Yman, Ph.D. Senior Chemist Swedish National
Food Administration, Livsmedels Verket to Ministry of Health in New Zealand,
May 30, 1997 (released under Official Information Act).
57. Fitzpatrick M. Soy formulas and the effects of isoflavones on the thyroid.
NZ Med J, 2000, 113, 1103, 24-26.
58. Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chem
Res Toxicol 1996, 9, 16-23.
59. Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean.
Biochem Pharmacol, 1997, 54, 1087-1096.
60. Committee on Toxicology (UK). Draft report of the COT Working Group on
Phytoestrogens. 4. Sources and concentrations of phytoestrogens in foods
and estimated dietary intake.
61. Jabbar MA, Larrea J, Shaw RA. Abnormal thyroid function test in infants
with congenital hypothyroidism: the influence of soy-based formula. J Am
Coll Nutr, 1997, 16, 280-282.
62. Fitzpatrick.
63. Irvine CHG, Fitzpatrick MG, Alexander SL. Phytoestrogens in soy-based
infant foods: concentrations, daily intake and possible biological effects.
Proc Soc Exp Biol Med, 1998, 217, 247-253.
64. Irvine CHG, Fitzpatrick M et al. The potential adverse effects of soybean
phytoestrogens in infant feeding. NZ Med J, 1995, 24, 318
65. Sharpe RM et al. Infant feeding with soy formula milk: effects on the
testis and on blood testosterone levels in marmoset monkeys during the period
of neonatal testicular activity. Hum Repro, 2002, 17, 7, 1692-1703.
66. Whitten PL, Lewis C et al. Potential adverse effects of phytoestrogens.
J Nutr, 1995, 125, 771S-776S.
67. Committee on Toxicology (UK). Draft report of the COT Working Group on
Phytoestrogens. 5: Absorption, distribution, metabolism and excretion of
phytoestrogens
68. Clarkson RB et al. Estrogen soybean isoflavones and chronic disease:
risks and benefits Trends, Endocrinol MEtab, 1995, 6, 11-16.
69. Kaldas RS, Hughes CL. Reproductive and general metabolic effects of phytoestrogens
in mammals. Repr Toxicol, 1989, 3, 81-89.
70. Irvine, Fitzpatrick, Alexander.
71. Santti R, Makela S et al. Phytoestrogens: potential endocrine disrupters
in males. Toxicol Envir Health, 1998, 14, 1-2, 223-237.
72. Frawley LS, Neill JD. Age-related changes in serum levels of gonadotropins
and testosterone in infantile male rhesus monkeys. Biol Repro 1979, 20, 1147-1151.
73. Mann DR, Gould KG et al. Blockade of neonatal activation of the pituitary
testicular axis: effect on peripubertal lutenizing hormone and testosterone
secretion and on testicular development in male monkeys J Clin Endocrinol
Metab, 1989, 68, 600-607.
74. Winter JSD, Hughes IA et al. Pituitary-gonadal relations in infancy:
patterns of serum gonadal steroid concentrations in man from birth to two
years of age. J Clin Endocrinol Metab, 1976, 42, 679-686.
75. Sedimeyer IL, Palmert MR. Delayed puberty: analysis of a large case series
from an academic center. J Clin Endocrinol Metab, 2002, 87, 4, 1613-1620.
76. Hutson J, Baker M. Hormonal control of testicular descent and the cause
of cryptorchidism. Repr Fert Dev, 1994, 6, 151-156.
77. Sharpe R, Shakkeback N. Are oestrogens involved in falling sperm counts
and disorders of the male reproductive tract? Lancet, 1993, 341, 1292-1395.]
78. Auger J, Kunstmann J et al. Decline in semen quality among fertile men
in Paris during the past 20 years. NEJM, 1995, 332, 5, 281-285.
79. Richard Sharpe MD, as quoted by Aileen Ballantyne in "Why our Men are
Getting Less Fertile," London Times, August 29, 1995.
80. Irvine, Fitzpatrick.
81. Winter, Hughes.
82. Mann, Gould.
83. Giddens, Herman et al. Secondary sexual characteristics and menses in
young girls seen in office practice. Study from the Pediatric Research in
Office Settings Network, 1997, 99, 4, 505-512.
84. Montague, Peter. Editorial: the obscenity of accelerated child development.
Ecologist, 1993, 28, 3, 140-142.
85. Zacharias L, Wurtman RJ. Age at menarche. NEJM, 1969, 280, 16, 868-875.
The articles includes results reported in Michaelson N. Studies in physical
development of Negroes. IV. Onset of puberty. Am J Phys Anthropol, 1944,
2, 151-166.
86. Fenton CL. Poth M. Precocious pseudopuberty. eMedicine, 2001, 2, 5, www.emedicine.com.
87. Irvine, Fitzpatrick.
88. Strom BL, Schinnar R et al. Exposure to soy-based formula in infancy
and endocrinological and reproductive outcomes in young adulthood. JAMA,
2001, 286, 7, 897-814.
89. Goldman LR, Newbold R, Swan S. Exposure to soy-based formula in infancy.
Letter to the Editor. JAMA, 2001, 286, 19, 2402-2403.
90. Silva M, Reynolds EC. Fluoride content of infant formulae in Australia.
Austr Dent J, 1996, 41, 1, 37-42.
91. Fomon SJ, Ekstrand J. Fluoride intake by infants. J Public Health Dent,
1999, 59, 4, 229-234.
92. Weintraub R, Hans G et al. High aluminum content of infant milk formulas.
Arch Dis Child, 1986, 61, 914-916.
93. Koo WWK, Kaplan LA, Krug-Wispe SK. Aluminum contamination of infant formulas.
J Parenteral Enterol Nutr, 1988, 12, 170-173.
94. Hawkins NM, Coffee S et al. Potential aluminum toxicity in infants fed
special infant formula. J Pediatr Gastroenterol Nutr, 1994, 19, 4, 377-381.
95. Tran TT, Chowanadisai W et al. Effect of high dietary manganese intake
of neonatal rats on tissue mineral accumulation, striatal dopamine levels
and neurodevelopmental status. Neurotoxicol, 2002, 23, 635-643.
96. Trans TT, Crinella FM et al. Effects of neonatal dietary manganese exposure
on brain dopamine levels and neurocognitive function. Neurotoxicol, 2002,
23, 645-651.
97. Stasny D, Voegl RS, Picciano MF. Manganese intake and serum manganese
concentration of human milk-fed and formula fed infants. Am J Clin Nutr,
1984, 39, 6, 872-878.
98. Collipp PJ, Chen SY, Maitinsky S. Manganese in infant formulas and learning
disability. Ann Nutr Metab, 1983, 27, 488-494.
99. Irvine, Fitzpatrick, Alexander.
100. Franke AA et al. Daidzein and genistein concentrations in human milk
after soy consumption. Clin Chem, 1996, 42, 955-964.
101. Setchell KDR et al. Exposure of infants to phyto-oestrogens from soy-based
infant formula. Lancet, 1997, 350 (9070) 23-27.
102. Declos KB et al. Effects of dietary genistein exposure during development
on male and female DC (Sprague-Dawley) rats. Repro Toxicol 1001, 15, 6, 647-663.
103. North K, Golding J, ALSPAC Study Team. A maternal vegetarian diet in
pregnancy is associated with hypospadias. BJU Inter, 2000, 85, 107-113.
104. Apfel RJ, Fischer SM. To Do No Harm: DES and the Dilemmas of Modern
Medicine (Yale University Press, 1984).
105. Setchell KDR. Naturally occurring non-steroidal estrogens of dietary
origin. In McLachlan John A ed. Estrogens in the Environment (Elsevier, 1985).
106. Baskin, Laurence, ed. Hypospadias and Genital Development (NY Kluwer/Plenum,
2004) 16, 28, 234
107. Bickoff, E.M., et al. "Relative potencies of several estrogen-like
compounds found in forages," Agri Food Chem., 1962, 10, 410.
108. Woodhams, David J., Nutritional Deficiencies in Soy Protein-based Infant
Formulas, paper presented to the New Zealand Ministry of Health, March 5,
1995.
109. Newbold RR, Banks EP et al. Uterine adenocarcinoma in mice treated prenatally
with genistein. Cancer Res, 2001, 61, 4325-4328.
110. Markiewicz L et al. In vitro bioassays of non-steroidal phytoestrogens.
J Steroids Biochem Mol Biol, 1993, 45, 5, 399-405.
111. Fallon, Sally. Table: Phytoestrogens in Diets of Infants and Adults.
Weston A. Price Foundation. For analysis and citations visit www.westonaprice.org/soy/dangersisoflavones.html
112. Sheehan DM. Isoflavone content of breast milk and soy formulas: benefits
and risks (letter). Clin Chem, 1997, 43, 850.
© 2006 Michigan Midwives Association. All Rights Reserved.
Site design and hosting provided by Starr-Rhapsody Creations.